HempCo plans to open the largest cannabis farm in Europe

The use of medical cannabis has been allowed in Germany for two years now, however, domestic cultivation hasn’t been approved in the country yet and cannabis has been imported mainly from Canada. The German company HempCo has huge plans for opening the largest cannabis farm in Europe. HempCo secures a strong position in the market for commercial cannabis products in Germany and Europe.

In Dresden, plans for the largest cannabis farm in Europe are currently taking shape. Some details of the large cultivation and processing plant near Dresden have already been revealed in recent weeks.

The manufacturer who wants to take the gigantic outdoor cultivation there into his own hands is not a German company in the true sense of the word. It is “German HempCo,” which belongs to the Canadian company Eurolife Brands. The company provides e-commerce services, operates as a marketplace for cannabis, and provides educational services, serving customers worldwide.

The Hemp.im application provides you with the most current and up-to-date marijuana investing news and covers wide-ranging topics including hemp and cannabis stocks.

As your official hemp news app, we also cover salient topics like the Hemp Farm Bill, the legality of hemp, the various health benefits of hemp as well as the multitude of products made from hemp: hemp shampoos, hemp conditioners, hemp tea, hemp paper, hemp backpacks, hemp oil, hemp bracelets, hemp beer, hemp houses, hemp shoes, hemp t-shirts, hemp creams, hemp water, hemp for dogs, hemp for cats, hemp honey, hemp jewelry, water-soluble hemp powder and more.

HempCo expands to create the biggest cannabis farm in Europe

German HempCo concentrates on cannabis cultivation on about 500 hectares of agricultural land in Saxony near Dresden. There is the option to expand the production by another 2,000 hectares. Should these plans be implemented, the largest cannabis farm in Europe would be achieved.

The new company already has existing assets and infrastructure for hemp production. In addition to the areas under cultivation and machinery for their management, HempCo is said to be in possession of 110 tons of cannabis biomass. Purchase contracts and orders already exist, as well as drying rooms and storage areas.

Wide range of possible uses for cannabis from Germany

HempCo has several options with regard to the further processing of harvested cannabis. By default cannabidiol (CBD) will be extracted for the production of food supplements and other CBD products.

In addition, besides the extraction of whole cannabis flower, the sustainable production of paper, alternatives for plastic packaging, fiber textiles and animal feed will be considered for the cannabis farm in Europe.

The company is also investigating possibilities to cultivate cannabis varieties with an increased concentration of cannabigerol (CBG.) In order to realize all possibilities, HempCo is looking for strong partnerships in production and distribution.

Parent company relocates to build a cannabis farm in Europe

With the extension project in Dresden, EuroLife Brands is responding to the announcement that in the future it intends to shift its business activities away from North America to Europe. Compared to America, the European markets are relatively underdeveloped and offer the company better growth opportunities.

In the U.S., especially in California, there is indeed cannabis cultivation on the scale of the Dresden project. However, these are spread over several plantations, while the area under cultivation by HempCo in Germany will be contiguous.

This offers logistical and organizational advantages for a cannabis farm in Europe. HempCo thus secures a strong position in the market for commercial cannabis products in Germany and Europe.

A positive aspect of undertaking the largest cannabis farm in Europe shows that the company is obviously counting on a strong acceptance of the CBD and cannabis industry.

__

(Featured image by Florian Weichelt via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Hanf Magazin, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.